This just out from our group: Based on >25,000 MM pts: Increased cumulative doses of alkylating therapy with melphalan increases the subsequent risk of developing AML/MDS in patients with MM #mmsm pubmed.ncbi.nlm.nih.gov/33966293/ Gudbjorg Jonsdottir, MD PhD C. Ola Landgren, M.D. Malin Hultcrantz MD PhD

Our full paper will soon be out in the European Journal of Haematology

What a great journey! Thank you so much for all your help and guidance!

Just a couple months before the end of her second year in our University of Iowa Health Care #HemOncFellowship, now Chief Fellow Gudbjorg Jonsdottir, MD PhD successfully defended her PhD dissertation at University of Iceland. Well done! Cc: @IowaPSTP UI Holden Comprehensive Cancer Center internalmedicineiowa.org/2021/07/21/jon…

University of Iowa Health Care Gudbjorg Jonsdottir, MD PhD University of Iceland @IowaPSTP UI Holden Comprehensive Cancer Center Worth noting that the last physician to earn a PhD from University of Iceland while also in one of our training programs was then-PGY3 Thorarinn A. Bjarnason MD PhD in 2019. Dr. Jonsdottir was there for his defense. internalmedicineiowa.org/2019/08/02/bja…

We pride ourselves on the mentorship & guidance our senior residents provide to our program and team. Dr. Asgeir Masson and Dr. Kelsey Koch were nominated for two ACS Awards for their work in promoting important competencies in medicine. Congrats Kelsey Koch & @asgeirthm #Iowa

The rising star in smoldering myeloma (SMM) Sigrun Thorsteinsdottir will present how common smoldering myeloma really is at 12 o'clock today! Spoiler alert: It is more common than you think... The iStopMM team is so proud of her! Sigurdur Kristinsson International Myeloma Foundation Binding Site

In less than 2 hours Sæmundur Rögnvaldsson, MD, PhD will tell you whether MGUS is a risk factor for #covid19 or severe covid. Don't miss it. He is an MD, a PhD student and a brilliant member of the iStopMM team! Sigurdur Kristinsson International Myeloma Foundation Binding Site

Are you curious what happens if you screen 75,000 people for MGUS? The PI for the iStopMM study, Sigurdur Kristinsson will literary tell you in just about 1 hour! Binding Site International Myeloma Foundation

Honored to be among Conquer Cancer, the ASCO Foundation ASCO Merit Award recipients! Thank you to my mentor Carlos HF Chan MD PhD and our collaborators at the #ORIEN cancer centers UI Holden Comprehensive Cancer Center Internal Medicine at Iowa @IowaPSTP Looking forward to presenting our work on HRD in PDAC at #ASCO2022

Looking forward to see everyone at #ASCO22!

#M2GEN’s Dr. Michelle Churchman (Michelle Churchman) joins Dr. Gudbjorg Jonsdottir (Gudbjorg Jonsdottir, MD PhD) at #ASCO22 as she presents work from her #ORIEN Intermember project: “The impact of HRD in patients with pancreatic adenocarcinoma who undergo surgical resection: an updated analysis.”